Pentobarbital will minimize the level or impact of saxagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unknown. pentobarbital will lower the extent or result of suvorexant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of. Sturdy CYP3A4 inducers could minimize suvorexant efficacy; if improved suvorexant dose esse... https://fidell887hxn5.thelateblog.com/profile